First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma...

Keywords

MedicineGastric adenocarcinomaGastro-ChemotherapyNivolumabInternal medicineGastroenterologyOpen labelAdenocarcinomaGastroesophageal JunctionOncologyClinical trialCancerRefluxImmunotherapyDisease

Affiliated Institutions

Related Publications

Quantitation of human left ventricular mass and volume by two-dimensional echocardiography: in vitro anatomic validation.

J Helak , Nathaniel Reichek

1981 Circulation 213 citations

Reproducibility of left ventricular volumes by two-dimensional echocardiography

Elaine Gordon , Ingela Schnittger , Peter J. Fitzgerald +2 more

1983 Journal of the American College of Ca... 187 citations

Cross-sectional echocardiography. I. Analysis of mathematic models for quantifying mass of the left ventricle in dogs.

H.L. Wyatt , Ming K. Heng , Samuel Meerbaum +4 more

Cross-sectional echocardiography was used to quantify left ventricular mass noninvasively in 21 dogs. Short- and long-axis cross-sectional images of the left ventricle were repr...

1979 Circulation 375 citations

Comparative accuracy of apical biplane cross-sectional echocardiography and gated equilibrium radionuclide angiography for estimating left ventricular size and performance.

Mark R. Starling , Michael H. Crawford , Sherman G. Sorensen +3 more

1981 Circulation 240 citations

Left ventricular volumes determined by two-dimensional echocardiography in a normal adult population

Dennis Wahr , Yin Shi Wang , Nelson B. Schiller

1983 Journal of the American College of Ca... 189 citations

Publication Info

Year: 2021
Type: article
Volume: 398
Issue: 10294
Pages: 27-40
Citations: 2580
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2580

OpenAlex

Cite This

APA Style

                            
                                
                                    Yelena Y. Janjigian, 
                                
                                    Kohei Shitara, 
                                
                                    Markus Moehler
                                
                                et al.
                            
                            (2021). 
                            First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. 
                            The Lancet
                            , 398
                            (10294)
                            , 27-40.
                            https://doi.org/10.1016/s0140-6736(21)00797-2
                        

Identifiers

DOI: 10.1016/s0140-6736(21)00797-2